A function of CD10 on bone marrow stroma
- 1 July 1994
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 87 (3) , 655-657
- https://doi.org/10.1111/j.1365-2141.1994.tb08335.x
Abstract
Bone marrow (BM) stromal cells express CD10 (cALLA), a surface antigen now known to be a neutral endopeptidase (NEP-24.11). The function of CD10 in BM stroma is unknown, although purified NEP-24.11 is known to degrade different substrates including interleukin 1 beta (IL-1 beta). We have therefore employed a CD10-positive BM stromal cell line (L2AK) which proliferates in response to IL-1 beta to test the hypothesis that degradation of this cytokine is one of the functions of stromal CD10. We first showed that [3H]thymidine incorporation by L2AK cells is enhanced by IL-1 beta in a clear dose-dependent manner. Addition of the CD10 inhibitor, phosphoramidon, together with IL-1 beta resulted in a left shift in the dose-response curve which corresponded to a 10-fold potentiation of the IL-1 beta effect. These results indicate that CD10 on bone marrow stromal cells can degrade IL-1 beta and therefore provide a local control of the effects of this, and possibly other, growth factor(s).Keywords
This publication has 7 references indexed in Scilit:
- The common acute lymphoblastic leukemia antigen (CD10)--emancipation from a functional enigmaBlood, 1989
- Common acute lymphocytic leukemia antigen is identical to neutral endopeptidase.The Journal of Experimental Medicine, 1988
- Effect of human endopeptidase 24.11 ("enkephalinase") on IL-1-induced thymocyte proliferation activity.The Journal of Immunology, 1988
- Bone marrow macrophages and megakaryocytes express common acute lymphoblastic leukaemia antigenLeukemia Research, 1985
- Granulocytes and cultured human fibroblasts express common acute lymphoblastic leukemia-associated antigensBlood, 1983
- Selective expression of the common acute lymphoblastic leukemia (gp 100) antigen on immature lymphoid cells and their malignant counterpartsBlood, 1983
- Antisera to acute lymphoblastic leukemia cellsClinical Immunology and Immunopathology, 1975